SOD1 and amyotrophic lateral sclerosis: In the first trial using ASOs in ALS-targeted SOD1, researchers administered intrathecal injections of ASO into rats and rhesus monkeys and demonstrated across-the-board coverage in the CNS and found slowing of disease progression in ALS rat models [32].